We have shown that daily treatment with melatonin (MT) markedly delays sexual maturation in the male rat. The observations that MT-treated rats have normal pituitary responsiveness t o G n W and low or absent pulsatile release of LH pointed out for a central inhibitory action of M T o n GnRH release. The sensitivity of m-treated rats to gonadectomy and sex steroid replacement was investigated: male rats receiving 100 pg MT daily or saline were castrated at 30 d and i d i a t e l y treated with various doses of testosterone propionate (T), or oil until sacrifice at 40 d. In animals that received oil, IH release was drastically reduced in MT-treated rats (46.0i7.3 nglml) as compared to controls (305*44) demonstrating that MT inhibits GnRH secretion i n absence of sex steroid. Replacement with T s h d that MT-treated rats were much more sensitive to T than controls, suggesting that MT potentiates the O feed-back action o f T on LH release. Conversely, the ability of G n W neurons of MT-treated rats to release GnRH i n response t o N-methyl-Dkaspartic acid (NMA), an excitatory amino acid analog known to cause LH release via G n W , was found normal at 30 d since NMA (20 mg/kg BW, iv) Conclusion: At the onset of puberty(G1) Lli is undetectable during the day, while during the night LH is secretedin a pulsatile pattern.During puberty LH level, pAand pNincrease, the night ahead. In C5 pN decreases, while pA still increases, presumable as a result of an increased negative feedback action of T. In contrast to LH, diurnal I:SH is detectable in G1, shows a clear increasealreadyin C2 and has no sleep-wake pattern.
I TIME LAGS BETWEEN VARIOUS MATURITY MEASURES AN0 SPERMARCHE. I
On the basis of biannual examinations of 40 normal boys followed longitudinally For a period of up to 7 years (initially agcd 8-Il), the following maturity measures were studied: first occurrcnce of o testis size OF more than 4 ml., pubic hair stage grcater than Tanner stage one, broken voice, axillary hair greater than stage one, beard growth, occurrence of acne and the age of maximal height growth velocity and spermarche (onset of the release of spermatozoa).
Spcrmarche was estimated on the basis of occurrence of spermatozoa in quarterly collccted 24-h urine samples, using the information of first occurrence oC spermaturia and the frequency of intermittent occurrence of spermaturia after the first.
With confidence limits of about t 4 months, the maturity measure showed the following time lags. Prior to spermarche: testis size >4 ml (16 months), pubic hair stage>l (10: months), first occurrence of broken voice (: month). After spermarche: max. height growth velocity ( S f months), axillary hair stage>l (8 months), growth of beard 112 months) and occurence of acne (13 months). 
I
We havc trcatcd 61 children (SlF, 10M) wirl~ ccntral precocious pubcrty using intranasal (CI-ser6) CnRH analogue (Buscrclin). Maximum duration of treatment was 3.7 I;rs in the girls and 3.0yrr in tlic boys. Mean dose (SD) of (0-Scr ) CnRH was 25.3 (9) pglkg in the girls and 18.6 (12) pglkg in the boys.
No side effects were seen. 5 paticnts stopped trcatment due t ( non-compliance. Of 27 childrcn who had puberty stage 2 -3 bcforc treatment, 20 arrested or regressed and 7 advanccd. Of 21 childrcn treated at stage 4 -5, 7 regressed and 14 had no alLcration. Mea? testicular volume in the boys was rcduccd from 9.2 (6) mls to 5(1.4) mls after 1 year of treatment.
Mean basal serum LH became elevated during trcatment, although there was a decrease in pcak stimulated LH concentrations.
nllAlrCA fell during the first year of treatment to below 1.0.
Mcight vclocity in the girls reduced from 9.0 -6.0 cmslyr during the second year of trcatment. Height for bonc age SOS incrcascd from -1.86 (1.5) to -1.1 (1.5) during the first 1. (TRH test) rince the 6th m. 13 (12th m) and fT3 (6th m) decreased significantly. though remaining in control range. 14, f14. PRL. AClll and adrenal hormones did not change significantly. Ultraranography of the pelvis shoved significant decreases of uterine (6th m) and ovarian (12th a ) volume; the ovarian structure did not progress and follicle dianeter was aluayr 9 mn. Clinicallthernographic evaluation of the breast rhoued a general-ized arrest o r regrerrian of its maturational patterns. Auxological data (rlouer bone maturation and growth velocity, louer SO scores for chronological and bone age, adult height prediction tending to inprove) suggested a good prognosis. Ue conclude that these results of intranasal Burerelin administration and the absence of serious ride effects make it advisable in the treatment of girls uith true precocious puberty.
